SCHEMBL25753880

SCHEMBL25753880

COC(=O)C[C@H](NC(=O)CNC(=O)OC(C)(C)C)c1cc(C)cc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.39
ALDH1A1 P00352 5/20 0.39
MAPT P10636 4/20 0.39
TSHR P16473 2/20 0.39
ITGB3 P05106 1/20 0.39
ITGB1 P05556 1/20 0.39
ITGAV P06756 1/20 0.39
ITGA5 P08648 1/20 0.39
ITGB5 P18084 1/20 0.39
ITGB6 P18564 1/20 0.39
ITGB8 P26012 1/20 0.39
ITGA8 P53708 1/20 0.39
LMNA P02545 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HTT P42858 1/20 0.35
NCOA1 Q15788 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24037104 0.93 GPR139 (0.37) HPGDALDH1A1MAPTTSHRLMNA
SCHEMBL24036814 0.89 HPGD (0.35) HPGDALDH1A1MAPTTSHRLMNA
SCHEMBL25753881 0.89 HPGD (0.35) HPGDALDH1A1MAPTTSHRLMNA
SCHEMBL24037106 0.88 GPR139 (0.40) HPGDALDH1A1MAPTTSHRITGB3
SCHEMBL25624220 0.88 ALDH1A1 (0.42) HPGDALDH1A1MAPTTSHRITGB3
SCHEMBL25753874 0.87 MAPT (0.39) HPGDALDH1A1MAPTTSHRITGB3
SCHEMBL25753791 0.87 ITGB3 (0.41) HPGDALDH1A1MAPTTSHRITGB3
SCHEMBL24036908 0.85 MAPT (0.38) HPGDALDH1A1MAPTTSHRITGB3
SCHEMBL24036832 0.85 WDR5 (0.44) HPGDALDH1A1LMNAKDM4EMEN1
SCHEMBL24036714 0.85 ITGB3 (0.43) HPGDALDH1A1MAPTTSHRITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE UBE CORPORATION (JP) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE DHFR, DPYD, CYP2D6 HPGD 1458/4885ALDH1A1 208/4885MAPT 3157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.